Full Text (PDF)
Case Report

Acute Pancreatitis: It’s not always “On the Rocks”

Himanshu Gupta

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

 This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Emergency Medicine 10(3):p 147-151, July-Sept. 2024. | DOI: https://doi.org/10.21088/ijem.2395.311X.10324.7

How Cite This Article:

Gupta H. Acute pancreatitis: it’s not always “on the rocks”. Ind J Emerg Med. 2024;10(3):147-51.

Timeline

Received : May 30, 2024         Accepted : August 05, 2024          Published : September 10, 2024

Abstract

Acute pancreatitis is one among the common causes of pain abdomen presenting to emergency department. Some of the most common causes of acute pancreatitis include gallstones, alcohol use, hypertriglyceridemia and Drugs. Over 500 drugs are implicated as a causative agents and account for less than 2% of cases. Sodium valproate, one of the commonly prescribed anti-epileptic drug is known to cause acute pancreatitis. Here, we are presenting a case of a 26-years-old male who is a known case of juvenile myoclonic epilepsy on sodium valproate who presented with acute pancreatitis. Our reasons for highlighting this case are: To illustrate a patient with juvenile myoclonic epilepsy on sodium valproate developing acute pancreatitis with other adverse effects like gum hypertrophy, vitamin B12 and folate deficiency.


References

  • 1.   Gardner T.B. Acute pancreatitis. Ann. Intern. Med. 2021;174:ITC17–ITC32. doi: 10.7326/ AITC202102160.
  • 2.   Walkowska J., Zielinska N., Karauda P., Tubbs R.S., Kurtys K., Olewnik L. The pancreas and known factors of acute pancreatitis. J Clin. Med. 2022;11:5565. doi: 10.3390/jcm11195565.
  • 3.   Barakat M.T., Abu-El-Haija M., Husain S.Z. Clinical insights into drug-associated pancreatic injury.Curr. Opin. Gastroenterol.2022;38:482–486. doi: 10.1097/MOG.0000000000000865.
  • 4.   Peterson G.M., Naunton M. Valproate: A simple chemical with so much to offer. J. Clin. Pharm. Ther. 2005;30:417–421. doi: 10.1111/j.1365-2710.2005.00671.x.
  • 5.   Wartman C., VandenBerg A. Valproate: Not all boxed warnings are created equal. Ann. Pharmacother. 2022;56:1349–1355. doi: 10.1177/10600280221085991.
  • 6.   Genton P, Gelisse P. Vaproic acid. Adverse effects. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Antipepileptic drugs. 5th ed. Lippincott William &Wilkins, Philadelphia, 2002;838–851.
  • 7.   Hamad AE, Fawzi ME. Valproate associated acute pancreatitis. Neurosciences. 2000;5(3):156–8.
  • 8.   Perrott J, Murphy NG, Zed PJ. L-carnitine for acute valproic acid overdose: a systematic review of published cases. Ann Pharmacother. 2010;44(7–8):1287–93.
  • 9.   Davis RB, Sunder TR, Barakat HA, May R. Valproate Alters the Membrane Phospholipids of Erythrocytes. Epilepsia. 1991;32;11-2.
  • 10.   Hallmon WW, Rossmann JA. The role of drugs in the pathogenesis of gingival overgrowth. Periodontol. 2000;1999(21):176.
  • 11.   Yazdani K, Lippmann M, Gala I. Fatal pancreatitis associated with valproic acid, review of the literature. Medicine. 2002;81(4):305–10.
  • 12.   Hamad AE, Fawzi ME. Valproate associated acute pancreatitis. Neurosciences. 2000;5(3):156–8.
  • 13.   Gerstner T, Büsing D, Bell N, Longin E, Kasper JM, Klostermann W, et al. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. J Gastroenterol. 2007;42:39–48.

Data Sharing Statement

There are no additional data available.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Acknowledgements

Information not provided.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Gupta H. Acute pancreatitis: it’s not always “on the rocks”. Ind J Emerg Med. 2024;10(3):147-51.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

 This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
May 30, 2024 August 05, 2024 September 10, 2024

DOI: https://doi.org/10.21088/ijem.2395.311X.10324.7

Keywords

Acute pancreatitisValproic acidValproateDrug inducedJuvenile myoclonic epilepsyAnticonvulsantsInterstitial pancreatitis

Article Level Metrics

Last Updated

Wednesday 17 June 2026, 12:38:30 (IST)


2146

Accesses

13
735
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received May 30, 2024
Accepted August 05, 2024
Published September 10, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

 This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share